These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 24008579)
1. Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants. Reinecke H; Engelbertz C; Schäbitz WR Stroke; 2013 Oct; 44(10):2935-41. PubMed ID: 24008579 [No Abstract] [Full Text] [Related]
2. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety. Salim I; Al Suwaidi J; Ghadban W; Salam AM Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103 [TBL] [Abstract][Full Text] [Related]
3. [Oral anticoagulation in chronic kidney disease with atrial fibrillation]. Expósito V; Seras M; Fernández-Fresnedo G Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748 [TBL] [Abstract][Full Text] [Related]
4. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation. Ahmad Y; Lip GY Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451 [TBL] [Abstract][Full Text] [Related]
5. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease. Turagam MK; Addepally NS; Velagapudi P Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517 [TBL] [Abstract][Full Text] [Related]
6. Stroke prevention in atrial fibrillation patients with chronic kidney disease. Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601 [TBL] [Abstract][Full Text] [Related]
7. [Prevention of stroke in patients with atrial fibrillation and chronic kidney disease: difficult choices and clinical decisions]. Gorczyca-Michta I; Kluk M; Wożakowska-Kapłon B Kardiol Pol; 2012; 70(9):948-52. PubMed ID: 22993008 [No Abstract] [Full Text] [Related]
8. New oral anticoagulants in patients with chronic kidney disease. Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514 [TBL] [Abstract][Full Text] [Related]
9. [Oral anticoagulation in patients with atrial fibrillation and chronic kidney disease]. Sánchez-Muñoz LA; Aguilar-Flores RA; Juanatey-García A; González de Zárate-Catón S Med Clin (Barc); 2015 May; 144(10):480. PubMed ID: 25256433 [No Abstract] [Full Text] [Related]
10. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines. Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343 [TBL] [Abstract][Full Text] [Related]
11. Ineligibility for anticoagulation in patients with atrial fibrillation. del Conde I; Halperin JL Am J Med; 2013 Feb; 126(2):105-11. PubMed ID: 23331435 [TBL] [Abstract][Full Text] [Related]
12. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
14. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation. Fernandez MM; von Schéele B; Hogue S; Kwong WJ Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283 [TBL] [Abstract][Full Text] [Related]
15. Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease. Qamar A; Bhatt DL Circulation; 2016 Apr; 133(15):1512-5. PubMed ID: 27067086 [No Abstract] [Full Text] [Related]
16. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients]. Reicke B; Masuhr F; Weih M Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772 [TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation in polypathological patients with atrial fibrillation]. Díez-Manglano J; Bernabeu-Wittel M; Barón-Franco B; Murcia-Zaragoza J; Fuertes Martín A; Alemán A; Ollero-Baturone M; Med Clin (Barc); 2013 Feb; 140(3):97-103. PubMed ID: 23199837 [TBL] [Abstract][Full Text] [Related]
18. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209 [TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013. Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181 [TBL] [Abstract][Full Text] [Related]
20. New oral anticoagulants: their role in stroke prevention in high-risk patients with atrial fibrillation. Ferns SJ; Naccarelli GV Med Clin North Am; 2015 Jul; 99(4):759-80. PubMed ID: 26042881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]